![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DexCom Increases IPO Pricing
DexCom Increases IPO Pricing
March 25, 2005
Venture-backed glucose monitoring systems maker DexCom has bumped up the value of its initial public offering (IPO) by 8 percent to $75.7 million. The San Diego, Calif.-based company set the terms of the 4.7 million share offering at $12 to $14 an issue. On Feb. 1, DexCom estimated the IPO's value at $70 million.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct